Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Line item | Abulpharm | Pharmed | GlobalPharm | Berlin-Chemie / A. Mena… | CIS Pharma |
|---|---|---|---|---|---|
| Total Current Assets | 372,077 | 53,482 | 116,622 | 15,487 | 50,145 |
| Total Non-Current Assets | 789 | 36,883 | 71,453 | 303 | 2,678 |
| TOTAL ASSETS | 372,866 | 90,365 | 188,074 | 15,790 | 52,823 |
| Total Current Liabilities | 135,495 | 12,852 | 125,430 | 5,774 | 20,066 |
| Total Non-Current Liabilities | 0 | 0 | 25,145 | 0 | 0 |
| TOTAL LIABILITIES | 135,495 | 12,852 | 150,575 | 5,774 | 20,066 |
| Total Equity | 237,371 | 77,513 | 37,499 | 10,016 | 32,757 |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 0 | 0 | 33,699 | 0 | 424 |
| Cash & Equivalents | 9,029 | 23,869 | 6,673 | 1,049 | 29 |
| Net Debt | -9,029 | -23,869 | 27,026 | -1,049 | 394 |
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Abulpharm | Pharma | 52.7% | 98th pct | 110 |
| CIS Pharma | Pharma | 51.7% | 97th pct | 110 |
| Pharmed | Pharma | 31.1% | 75th pct | 110 |
| GlobalPharm | Pharma | 16.4% | 52nd pct | 110 |
| Berlin-Chemie / A. Mena… | Pharma | 3.6% | 19th pct | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.